Two Sigma Securities »

Lava Therapeutics Nv shares owned by Two Sigma Securities

Quarter-by-quarter ownership of Lava Therapeutics Nv (LVTX) shares owned by Two Sigma Securities from 13F filings

Historical chart of Two Sigma Securities investment in Lava Therapeutics Nv

Tip: Access up to 7 years of quarterly data

All positions including Lava Therapeutics Nv held by Two Sigma Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lava Therapeutics Nv by Two Sigma Securities

Quarter filed Position value Share count Share price at filing
2024-03-31 $43k 13k 3.33

More positions owned by Two Sigma Securities

NVIDIA Corporation Call Option (NVDA)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Chevron Corporation (CVX)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Broadcom (AVGO)
Super Micro Computer Call Option (SMCI)
Eli Lilly & Co. Call Option (LLY)
Lockheed Martin Corporation Call Option (LMT)

View all positions for Two Sigma Securities

Top funds holding Lava Therapeutics Nv

Redmile Group
Bruce & Co
Sphera Funds Management
Walleye Trading Advisors
Falcon Edge Capital
Two Sigma Investments
Pnc Financial Services
Citadel Advisors
Millennium Management
Schonfeld Strategic Advisors
Susquehanna International
Two Sigma Advisers
Bank of America Corporation
Pathway Financial Advisors
Two Sigma Securities

View all funds holding Lava Therapeutics Nv